Mayo Clinic

(redirected from Mayo Foundation)
Also found in: Encyclopedia.

Mayo Clinic

A non-profit tertiary care centre in Rochester, Minnesota, which was founded by William Mayo Sr and his two sons, William and Charles, in 1889. The Mayo Clinic is consistently ranked in the top 5 of the US News & World Report’s annual reports on healthcare; it has satellite units in Scottsdale, Arizona, and Jacksonville, Florida.
References in periodicals archive ?
District Court for the District of Minnesota held that the stipends the Mayo Foundation paid to its residents were not subject to FICA because the residents satisfied the student exception under regulations then in effect (282 F.
The most immediate effects of the Mayo Foundation decision will be felt in litigation, where challenges to regulations will center on the substance of the regulations rather than their history.
Mayo Clinic Proceedings is published monthly by Mayo Foundation for Medical Education and Research as part of its commitment to the medical education of physicians.
In 2003, a district court held in Mayo Foundation that a case-by-case examination was required to determine whether medical residents are eligible for the student exemption (Mayo I).
In the private sector, these include ABB, AT&T, AXA, Bristol-Myers Squibb, Capgemini, Capital One, Deloitte Consulting, EDGAR Online, Ford, GMAC, Hewlett-Packard, Kaiser Permanente, Mayo Foundation, PricewaterhouseCoopers, SAP, UBS and Verizon.
Survivors include his wife, Margo, and daughter, who request that in lieu of flowers donations be sent to the Mayo Foundation at 200 S.
Customers include Visa, Bank of America, Sabre Holdings, Comcast, Federated Investors, Mayo Foundation and Overstock.
Mayo Foundation for Medical Education and Research, 282 FSupp2d 997, made it possible to apply the student exception to medical students.
GlaxoSmithKline, Mayo Foundation for Medical Education and Research.
SinuNase is a novel application and formulation of a known anti-fungal exclusively licensed from the Mayo Foundation for Medical Education and Research.
The Company's SinuNase product, in development to treat chronic sinusitis (rhinosinusitis), is a novel application and formulation of a known anti-fungal licensed from the Mayo Foundation for Medical Education and Research.
License with Mayo Foundation for Medical Education and Research Enables Clinical Data's PGxHealth Division to Test for Mutations Associated with Adverse Reactions to Irinotecan